Selected research
Market Outlook & Growth Opportunities
Global ELISA Assay Service Market Outlook and Growth Opportunities 2026
Market perspective
The global ELISA Assay Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for ELISA Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for ELISA Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for ELISA Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the ELISA Assay Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the ELISA Assay Service market include Boster Bio, RayBiotech, R&D Systems, Inc, ELISA Technologies, Inc., Cellular Technology Limited, Virology Research Services Ltd, Chimera Biotec, NorthEast BioLab and Sino Biological, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global ELISA Assay Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of ELISA Assay Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents ELISA Assay Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global ELISA Assay Service market.
ELISA Assay Service Segment by Company
Boster Bio
RayBiotech
R&D Systems, Inc
ELISA Technologies, Inc.
Cellular Technology Limited
Virology Research Services Ltd
Chimera Biotec
NorthEast BioLab
Sino Biological, Inc
Kaneka Eurogentec S.A.
Prove Laboratory Services
KCAS Bio
BioCat GmbH
Aviva Systems Biology Corporation
Eve Technologies
Boster Biological Technology
Bio-Techne
Precision Medicine Group, LLC
ACROBiosystems
mabtech
Cellular Technology Limited(immunospot)
Pestka Biomedical Laboratories, Inc
ProteoGenix
Kaneka Eurogentec S.A
ELISA Assay Service Segment by Type
Direct ELISA
Indirect ELISA
ELISA Assay Service Segment by Application
Disease Diagnosis
Vaccine Effectiveness Evaluation
Drug Development
Allergen Testing
Others
ELISA Assay Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global ELISA Assay Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the ELISA Assay Service key companies, revenue, market share, and recent developments.
3. To split the ELISA Assay Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions ELISA Assay Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify ELISA Assay Service significant trends, drivers, influence factors in global and regions.
6. To analyze ELISA Assay Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ELISA Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ELISA Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ELISA Assay Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global ELISA Assay Service industry.
Chapter 3: Detailed analysis of ELISA Assay Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of ELISA Assay Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of ELISA Assay Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Direct ELISA
- Indirect ELISA
Applications
- Disease Diagnosis
- Vaccine Effectiveness Evaluation
- Drug Development
- Allergen Testing
- Others
Companies covered
- Boster Bio
- RayBiotech
- R&D Systems, Inc
- ELISA Technologies, Inc.
- Cellular Technology Limited
- Virology Research Services Ltd
- Chimera Biotec
- NorthEast BioLab
- Sino Biological, Inc
- Kaneka Eurogentec S.A.
- Prove Laboratory Services
- KCAS Bio
- BioCat GmbH
- Aviva Systems Biology Corporation
- Eve Technologies
- Boster Biological Technology
- Bio-Techne
- Precision Medicine Group, LLC
- ACROBiosystems
- mabtech
- Cellular Technology Limited(immunospot)
- Pestka Biomedical Laboratories, Inc
- ProteoGenix
- Kaneka Eurogentec S.A
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global ELISA Assay Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global ELISA Assay Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 ELISA Assay Service Market Dynamics
- 2.1 ELISA Assay Service Industry Trends
- 2.2 ELISA Assay Service Industry Drivers
- 2.3 ELISA Assay Service Industry Opportunities and Challenges
- 2.4 ELISA Assay Service Industry Restraints
3 ELISA Assay Service Market by Company
- 3.1 Global ELISA Assay Service Company Revenue Ranking in 2025
- 3.2 Global ELISA Assay Service Revenue by Company (2021-2026)
- 3.3 Global ELISA Assay Service Company Ranking (2024-2026)
- 3.4 Global ELISA Assay Service Company Manufacturing Base and Headquarters
- 3.5 Global ELISA Assay Service Company Product Type and Application
- 3.6 Global ELISA Assay Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global ELISA Assay Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 ELISA Assay Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 ELISA Assay Service Market by Type
- 4.1 ELISA Assay Service Type Introduction
- 4.1.1 Direct ELISA
- 4.1.2 Indirect ELISA
- 4.2 Global ELISA Assay Service Sales Value by Type
- 4.2.1 Global ELISA Assay Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global ELISA Assay Service Sales Value by Type (2021-2032)
- 4.2.3 Global ELISA Assay Service Sales Value Share by Type (2021-2032)
5 ELISA Assay Service Market by Application
- 5.1 ELISA Assay Service Application Introduction
- 5.1.1 Disease Diagnosis
- 5.1.2 Vaccine Effectiveness Evaluation
- 5.1.3 Drug Development
- 5.1.4 Allergen Testing
- 5.1.5 Others
- 5.2 Global ELISA Assay Service Sales Value by Application
- 5.2.1 Global ELISA Assay Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global ELISA Assay Service Sales Value by Application (2021-2032)
- 5.2.3 Global ELISA Assay Service Sales Value Share by Application (2021-2032)
6 ELISA Assay Service Regional Value Analysis
- 6.1 Global ELISA Assay Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global ELISA Assay Service Sales Value by Region (2021-2032)
- 6.2.1 Global ELISA Assay Service Sales Value by Region: 2021-2026
- 6.2.2 Global ELISA Assay Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America ELISA Assay Service Sales Value (2021-2032)
- 6.3.2 North America ELISA Assay Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe ELISA Assay Service Sales Value (2021-2032)
- 6.4.2 Europe ELISA Assay Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific ELISA Assay Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific ELISA Assay Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America ELISA Assay Service Sales Value (2021-2032)
- 6.6.2 South America ELISA Assay Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa ELISA Assay Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa ELISA Assay Service Sales Value Share by Country, 2025 VS 2032
7 ELISA Assay Service Country-level Value Analysis
- 7.1 Global ELISA Assay Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global ELISA Assay Service Sales Value by Country (2021-2032)
- 7.2.1 Global ELISA Assay Service Sales Value by Country (2021-2026)
- 7.2.2 Global ELISA Assay Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt ELISA Assay Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt ELISA Assay Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt ELISA Assay Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Boster Bio
- 8.1.1 Boster Bio Company Information
- 8.1.2 Boster Bio Business Overview
- 8.1.3 Boster Bio ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Boster Bio ELISA Assay Service Product Portfolio
- 8.1.5 Boster Bio Recent Developments
- 8.2 RayBiotech
- 8.2.1 RayBiotech Company Information
- 8.2.2 RayBiotech Business Overview
- 8.2.3 RayBiotech ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.2.4 RayBiotech ELISA Assay Service Product Portfolio
- 8.2.5 RayBiotech Recent Developments
- 8.3 R&D Systems, Inc
- 8.3.1 R&D Systems, Inc Company Information
- 8.3.2 R&D Systems, Inc Business Overview
- 8.3.3 R&D Systems, Inc ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.3.4 R&D Systems, Inc ELISA Assay Service Product Portfolio
- 8.3.5 R&D Systems, Inc Recent Developments
- 8.4 ELISA Technologies, Inc.
- 8.4.1 ELISA Technologies, Inc. Company Information
- 8.4.2 ELISA Technologies, Inc. Business Overview
- 8.4.3 ELISA Technologies, Inc. ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.4.4 ELISA Technologies, Inc. ELISA Assay Service Product Portfolio
- 8.4.5 ELISA Technologies, Inc. Recent Developments
- 8.5 Cellular Technology Limited
- 8.5.1 Cellular Technology Limited Company Information
- 8.5.2 Cellular Technology Limited Business Overview
- 8.5.3 Cellular Technology Limited ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Cellular Technology Limited ELISA Assay Service Product Portfolio
- 8.5.5 Cellular Technology Limited Recent Developments
- 8.6 Virology Research Services Ltd
- 8.6.1 Virology Research Services Ltd Company Information
- 8.6.2 Virology Research Services Ltd Business Overview
- 8.6.3 Virology Research Services Ltd ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Virology Research Services Ltd ELISA Assay Service Product Portfolio
- 8.6.5 Virology Research Services Ltd Recent Developments
- 8.7 Chimera Biotec
- 8.7.1 Chimera Biotec Company Information
- 8.7.2 Chimera Biotec Business Overview
- 8.7.3 Chimera Biotec ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Chimera Biotec ELISA Assay Service Product Portfolio
- 8.7.5 Chimera Biotec Recent Developments
- 8.8 NorthEast BioLab
- 8.8.1 NorthEast BioLab Company Information
- 8.8.2 NorthEast BioLab Business Overview
- 8.8.3 NorthEast BioLab ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.8.4 NorthEast BioLab ELISA Assay Service Product Portfolio
- 8.8.5 NorthEast BioLab Recent Developments
- 8.9 Sino Biological, Inc
- 8.9.1 Sino Biological, Inc Company Information
- 8.9.2 Sino Biological, Inc Business Overview
- 8.9.3 Sino Biological, Inc ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Sino Biological, Inc ELISA Assay Service Product Portfolio
- 8.9.5 Sino Biological, Inc Recent Developments
- 8.10 Kaneka Eurogentec S.A.
- 8.10.1 Kaneka Eurogentec S.A. Company Information
- 8.10.2 Kaneka Eurogentec S.A. Business Overview
- 8.10.3 Kaneka Eurogentec S.A. ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Kaneka Eurogentec S.A. ELISA Assay Service Product Portfolio
- 8.10.5 Kaneka Eurogentec S.A. Recent Developments
- 8.11 Prove Laboratory Services
- 8.11.1 Prove Laboratory Services Company Information
- 8.11.2 Prove Laboratory Services Business Overview
- 8.11.3 Prove Laboratory Services ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Prove Laboratory Services ELISA Assay Service Product Portfolio
- 8.11.5 Prove Laboratory Services Recent Developments
- 8.12 KCAS Bio
- 8.12.1 KCAS Bio Company Information
- 8.12.2 KCAS Bio Business Overview
- 8.12.3 KCAS Bio ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.12.4 KCAS Bio ELISA Assay Service Product Portfolio
- 8.12.5 KCAS Bio Recent Developments
- 8.13 BioCat GmbH
- 8.13.1 BioCat GmbH Company Information
- 8.13.2 BioCat GmbH Business Overview
- 8.13.3 BioCat GmbH ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.13.4 BioCat GmbH ELISA Assay Service Product Portfolio
- 8.13.5 BioCat GmbH Recent Developments
- 8.14 Aviva Systems Biology Corporation
- 8.14.1 Aviva Systems Biology Corporation Company Information
- 8.14.2 Aviva Systems Biology Corporation Business Overview
- 8.14.3 Aviva Systems Biology Corporation ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Aviva Systems Biology Corporation ELISA Assay Service Product Portfolio
- 8.14.5 Aviva Systems Biology Corporation Recent Developments
- 8.15 Eve Technologies
- 8.15.1 Eve Technologies Company Information
- 8.15.2 Eve Technologies Business Overview
- 8.15.3 Eve Technologies ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Eve Technologies ELISA Assay Service Product Portfolio
- 8.15.5 Eve Technologies Recent Developments
- 8.16 Boster Biological Technology
- 8.16.1 Boster Biological Technology Company Information
- 8.16.2 Boster Biological Technology Business Overview
- 8.16.3 Boster Biological Technology ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Boster Biological Technology ELISA Assay Service Product Portfolio
- 8.16.5 Boster Biological Technology Recent Developments
- 8.17 Bio-Techne
- 8.17.1 Bio-Techne Company Information
- 8.17.2 Bio-Techne Business Overview
- 8.17.3 Bio-Techne ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Bio-Techne ELISA Assay Service Product Portfolio
- 8.17.5 Bio-Techne Recent Developments
- 8.18 Precision Medicine Group, LLC
- 8.18.1 Precision Medicine Group, LLC Company Information
- 8.18.2 Precision Medicine Group, LLC Business Overview
- 8.18.3 Precision Medicine Group, LLC ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Precision Medicine Group, LLC ELISA Assay Service Product Portfolio
- 8.18.5 Precision Medicine Group, LLC Recent Developments
- 8.19 ACROBiosystems
- 8.19.1 ACROBiosystems Company Information
- 8.19.2 ACROBiosystems Business Overview
- 8.19.3 ACROBiosystems ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.19.4 ACROBiosystems ELISA Assay Service Product Portfolio
- 8.19.5 ACROBiosystems Recent Developments
- 8.20 mabtech
- 8.20.1 mabtech Company Information
- 8.20.2 mabtech Business Overview
- 8.20.3 mabtech ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.20.4 mabtech ELISA Assay Service Product Portfolio
- 8.20.5 mabtech Recent Developments
- 8.21 Cellular Technology Limited(immunospot)
- 8.21.1 Cellular Technology Limited(immunospot) Company Information
- 8.21.2 Cellular Technology Limited(immunospot) Business Overview
- 8.21.3 Cellular Technology Limited(immunospot) ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.21.4 Cellular Technology Limited(immunospot) ELISA Assay Service Product Portfolio
- 8.21.5 Cellular Technology Limited(immunospot) Recent Developments
- 8.22 Pestka Biomedical Laboratories, Inc
- 8.22.1 Pestka Biomedical Laboratories, Inc Company Information
- 8.22.2 Pestka Biomedical Laboratories, Inc Business Overview
- 8.22.3 Pestka Biomedical Laboratories, Inc ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.22.4 Pestka Biomedical Laboratories, Inc ELISA Assay Service Product Portfolio
- 8.22.5 Pestka Biomedical Laboratories, Inc Recent Developments
- 8.23 ProteoGenix
- 8.23.1 ProteoGenix Company Information
- 8.23.2 ProteoGenix Business Overview
- 8.23.3 ProteoGenix ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.23.4 ProteoGenix ELISA Assay Service Product Portfolio
- 8.23.5 ProteoGenix Recent Developments
- 8.24 Kaneka Eurogentec S.A
- 8.24.1 Kaneka Eurogentec S.A Company Information
- 8.24.2 Kaneka Eurogentec S.A Business Overview
- 8.24.3 Kaneka Eurogentec S.A ELISA Assay Service Revenue and Gross Margin (2021-2026)
- 8.24.4 Kaneka Eurogentec S.A ELISA Assay Service Product Portfolio
- 8.24.5 Kaneka Eurogentec S.A Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst